Mylan Launches Another Generic Extended-Cycle Birth Control
Mylan has introduced a generic form of Teva's Seasonique extended-cycle birth control pill to the US market.
Mylan has introduced a generic form of Teva's Seasonique extended-cycle birth control pill to the US market.
Mylan's partner, Famy Care Ltd, recently received FDA approval for levonorgestrel and ethinyl estradiol 0.15 mg/0.03 mg tablets and ethinyl estradiol 0.01 mg tablets, which are indicated to prevent pregnancy in women who choose to use extended-cycle oral contraceptives that give them 4 menstrual periods per year instead of 1 per month.
This is the newest addition to Mylan's generic oral contraceptive line in the United States. Last month, the company began shipping a
Cigarette smoking is not advised in women who use any oral contraceptives, as it can increase the risk for cardiovascular side effects.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
Effectively Managing Immunizations in the Long-Term Care SettingSeptember 18th 2025
Creating a Culture of Quality in Fast-Melt Tablet DevelopmentSeptember 18th 2025
Advise Patients About Self-Care Measures to Treat Mild to Moderate GI IssuesSeptember 18th 2025
